Feedback / Questions
ADCT-601 - Overland ADCT BioPharma
camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics
ADCT-901 - Overland ADCT BioPharma
https://www.businesswire.com/news/home/20210506005624/en/ADC-Therapeutics-Reports-First-Quarter-2021-Financial-Results-and-Provides-Business-Updates
May 6, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next